Dendritic cells from patients with chronic myeloid leukemia: Functional and phenotypic features

被引：11
作者：
Eisendle, K
Wolf, D
Gastl, G
Kircher-Eibl, B
机构：
[1] Innsbruck Med Univ, Dept Dermatol, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Lab Tumor & Immunobiol, Div Hematol & Oncol, Innsbruck, Austria
来源：
LEUKEMIA & LYMPHOMA | 2005年 / 46卷 / 05期
关键词：
CML; dendritic cell; immunotherapy; imatinib mesylate; T cell; tumor necrosis factor-alpha; vaccination;
D O I：
10.1080/10428190400029825
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Dendritic cells (DCs) are professional antigen-presenting cells playing a pivotal role in the induction of humoral and cellular immune responses, and chronic myeloid leukemia-derived DCs (CML-DCs) are possible candidates for inducing anti-leukemic immunity. This review describes phenotypic and functional features of DCs derived from CML patients as compared with DCs from healthy volunteers. In short, distinct deficiencies have been reported for CML-DCs, such as reduced migration, endocytosis, phagocytosis, antigen processing, DC maturation and cytokine production. DC abnormalities of CML patients can be abrogated by proper in vitro stimulation of leukemic DCs. This underscores the importance of proper generation and maturation of CML-DCs when considering clinical vaccination protocols.
引用
收藏
页码：663 / 670
页数：8
相关论文
共 68 条
[61]   Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-α [J].
Wang, C ;
Al-Omar, HM ;
Radvanyi, L ;
Banerjee, A ;
Bouman, D ;
Squire, J ;
Messner, HA .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) :1176-1184
[62]   Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance [J].
Wang, HW ;
Cheng, FD ;
Cuenca, A ;
Horna, P ;
Zheng, Z ;
Bhalla, K ;
Sotomayor, EM .
BLOOD, 2005, 105 (03) :1135-1143
[63]   Dendritic cells become BCR-ABL negative in chronic myeloid leukaemia patients successfully treated with imatinib [J].
Wang, L ;
Butt, NM ;
Atherton, MG ;
Clark, RE .
LEUKEMIA, 2004, 18 (05) :1025-1027
[64]   Cryopreservation of mature monocyte-derived human dendritic cells for vaccination:: influence on phenotype and functional properties [J].
Westermann, J ;
Körner, IJ ;
Kopp, J ;
Kurz, S ;
Zenke, M ;
Dörken, B ;
Pezzutto, A .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (03) :194-198
[65]  
Wolf AM, 2003, CLIN CANCER RES, V9, P606
[66]   Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia [J].
Yotnda, P ;
Firat, H ;
Garcia-Pons, F ;
Garcia, Z ;
Gourru, G ;
Vernant, JP ;
Lemonnier, FA ;
Leblond, V ;
Langlade-Demoyen, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (10) :2290-2296
[67]   Generation of dendritic cells from peripheral blood of patients at different stages of chronic myeloid leukemia [J].
Zheng, C ;
Pisa, P ;
Stromberg, O ;
Blennow, E ;
Hansson, M .
MEDICAL ONCOLOGY, 2000, 17 (04) :270-278
[68]   A DISTINCT PATTERN OF CYTOKINE GENE-EXPRESSION BY HUMAN CD83(+) BLOOD DENDRITIC CELLS [J].
ZHOU, LJ ;
TEDDER, TF .
BLOOD, 1995, 86 (09) :3295-3301
1234567